Posted by: Northwest Eye in conjunctival melanosis on March 27, 2026
Know what conjunctival melanosis means
Conjunctival melanosis is pigmentation on the conjunctiva, the surface tissue covering much of the eye. Several lesions and medical conditions can cause this pigmentation, and most conjunctival neoplasms are benign. A dark area can still need an eye examination because appearance alone does not show which type is present.
Primary acquired melanosis, or PAM, is an acquired, flat, painless, noncystic pigmented lesion affecting the conjunctiva. PAM affects the conjunctival epithelium, the surface layer of that tissue. It usually affects one eye and is most common in middle-aged White adults.
PAM accounts for 11% of all conjunctival tumors and 21% of all conjunctival melanocytic lesions. These percentages describe the share of those reported tumor groups represented by PAM; they do not identify the cause of a particular spot. One management review reports that up to 75% of conjunctival melanomas arise from PAM and that these melanomas have a better prognosis than melanomas arising independently. That finding does not determine the risk of your pigmentation.
The useful starting point is not a color comparison at home. It is a baseline examination that records what the area looks like, where it is located, and whether it involves one or both eyes.
Start with when and where the pigmentation appeared
The timing and location of eye pigmentation help organize an examination. Tell your eye doctor when you first noticed it, how long it has been present, whether it stayed stable, and whether it has spread or changed. Also note whether the area is in one eye or both, whether it is on the visible white surface or under an eyelid, and whether you have earlier photographs.
Conjunctival pigmented lesions can be benign, premalignant, or malignant. They may be congenital, meaning present from birth, or acquired later. Rarely, pigmentation is linked to a medical disorder or a medicine. UV overexposure is believed to be a major risk factor for PAM, but that possible association does not explain every pigmented area.
Ocular melanocytosis is usually congenital and affects the episclera. It usually affects one eye and may occur with nearby skin pigmentation. Secondary melanosis can be linked to conditions such as Addison disease or to a medication side effect; these lesions do not have malignant potential.
Your history gives the examination a timeline. A spot present for many years, a new spot noticed recently, and a spot that has changed over time may look different, but none can be classified safely from history alone.
Compare the common patterns of pigmentation
Pigmented areas can share features, so an eye doctor compares several patterns rather than relying on color alone.
| Pattern | Usual history and appearance | What the pattern can suggest |
|---|---|---|
| Complexion-associated or racial melanosis | Usually flat, near the limbus, and present in both eyes; more common with darker-pigmented skin | This pattern is generally considered benign. Sources differ slightly on whether the risk is absent or extremely small, so a new or changing area still deserves assessment. |
| [Conjunctival nevus | Usually present since](https://aao.org/education/current-insight/conjunctival-melanoma-rare-deadly) childhood; typically raised, well defined, one-sided, and sometimes marked by tiny cysts | A selected clinical table reports that less than 1% of conjunctival nevi progress to conjunctival melanoma. That percentage describes the table’s reported nevus group, not an individual spot. |
| Ocular melanocytosis | Usually present from birth; affects the bulbar conjunctiva and episclera, often with nearby skin pigmentation | The pigment is deeper than a simple surface discoloration and usually affects one eye. |
| PAM | Usually acquired, flat, unevenly pigmented, noncystic, and found in one eye | Tissue findings determine whether PAM is without atypia or with atypia, which changes the level of concern. |
Sources describe complexion-associated melanosis as usually bilateral and without malignancy risk, while another source describes racial melanosis as rarely becoming conjunctival melanoma. The practical point is the same: do not label a new area from a photograph or mirror view. Have the pattern assessed, especially if it is changing.
The amount of conjunctiva involved also matters. One report found that PAM involving 4 clock hours was 7 times more likely to develop melanoma, while involvement of 12 clock hours was 20 times more likely. A clock hour is a way to describe how much of the eye’s surface is involved, not a measure of time. Those figures describe reported relative risk at two lesion extents; they do not predict what will happen to your eye.
Notice the features and timeline that matter
PAM is usually painless, flat, and without symptoms. It most often affects the bulbar conjunctiva, the exposed surface of the eye, and has no cysts. In one reported series, 57% of PAM lesions were located in the temporal quadrant, the side closer to the temple.
PAM can have uneven pigmentation. Its size or color may change over time, and the area may wax and wane on its own. Some pigmentation appears darker as daylight hours increase. PAM can also remain dormant for years or progress slowly, so a long history does not by itself establish that the area is harmless.
PAM is more concerning when it is thick, has a basal diameter greater than 2 clock hours, has feeder blood vessels or bleeding, or involves the fornix or tarsal conjunctiva. The fornix is the fold where the eyelid meets the eye surface; the tarsal conjunctiva lines the inner eyelid. A raised or thickened area, irregular shape, mixed colors, or prominent vessels can also make melanoma more concerning. Melanoma may look brown, another color, or pink.
PAM is most often found in White adults in the sixth decade of life. The mean age at diagnosis in one reported group was 56 years, with a range of 15 to 90 years, although PAM can occur in people of other racial backgrounds. Age and appearance help an eye doctor plan the evaluation; they do not diagnose the lesion. Because PAM can wax and wane, a darker appearance at one visit does not by itself prove progression. Earlier photographs give the clinician a way to compare the area over time. The comparison can help distinguish a change in visible pigment from other findings, such as new thickness, vessels, bleeding, or spread.
Understand what happens during an eye examination
An eye examination begins with the lesion’s history and a careful look at both eyes. Your eye doctor compares when the area appeared, whether it has changed, and whether it affects one or both eyes. The examination also considers location, shape, thickness, cysts, blood vessels, and whether the pigment reaches the cornea.
A slit-lamp examination is part of the clinical evaluation. Evaluation may also include a fundus examination, which checks the inside and back of the eye, and baseline photographs. Earlier photographs can show whether the area has changed between visits.
When more detail is needed, the examination may include ultrasound biomicroscopy. The latter is imaging of the front part of the eye that can help show tissue structure. These tests are selected according to the lesion’s appearance and history.
Appearance alone cannot determine what a pigmented conjunctival lesion is or how risky it may be. An eye doctor considers your age, the lesion’s appearance and location, whether one or both eyes are involved, and the examination findings. Bring earlier photographs, a list of medicines, and your best estimate of when you first noticed the area. If an examination raises concern about invasion or spread, additional imaging may be used. The test chosen depends on the clinical findings, so not every person with conjunctival pigmentation needs every imaging study.
Learn what a biopsy can clarify
A biopsy examined under a microscope can show whether PAM has atypia, meaning abnormal melanocyte changes in the tissue.
A tissue result adds information that a surface view cannot provide. Ask whether the proposed biopsy is intended to identify the lesion, determine atypia, remove the area, or do more than one of those jobs. Ask how the result would change monitoring or treatment.
A 2013 guideline recommended excision with cryotherapy to the margins for moderate-sized PAM occupying 2 to 5 clock hours. That recommendation applies to a defined lesion size and clinical setting, not to every pigmented area. Risk is also higher when PAM is thicker, has a basal diameter greater than 2 clock hours, has feeder vessels or bleeding, or involves a forniceal or tarsal location.
A biopsy result must be interpreted with the examination and the lesion’s extent. A tissue label alone does not set your follow-up schedule. If tissue shows atypia, that result can change the discussion toward treatment. The clinician still considers the lesion’s location, extent, and visible features because management depends on the full clinical picture. A biopsy result informs the plan but does not replace assessment of the eye over time.
Frame the PAM biopsy-versus-monitoring discussion
Use PAM’s specific features to frame a biopsy-versus-monitoring discussion. The focus is what the examination shows, what a biopsy could clarify, and how repeated treatment could affect the eye. A size-based algorithm is a discussion aid, not a personal schedule.
| Decision point | What the evidence describes | What to clarify with your eye doctor |
|---|---|---|
| Amount of conjunctiva involved | One published algorithm describes close monitoring for less than 2 clock hours, excisional biopsy and cryotherapy for 2–5 clock hours, and wider biopsy with cryotherapy for more than 5 clock hours | Whether this algorithm applies to the lesion’s other findings and location |
| Features that raise concern | Some specialists consider biopsy when there is thickness, internal blood supply, feeder vessels, progression, or multiple melanoma risk factors | Which of these findings are present; they do not establish a diagnosis by themselves |
| This differs from algorithms that use lesion extent to describe monitoring, excision, and cryotherapy. The difference is one reason to ask which specific finding is driving the discussion rather than relying on size alone. |
At the appointment, ask whether the area is flat or thickened, whether it has feeder vessels or bleeding, and how much conjunctiva it involves. Ask whether earlier photographs would help show change. If monitoring is proposed, ask what change would prompt another assessment or tissue sampling. PAM may wax and wane, so its appearance can differ between visits without providing a diagnosis on its own. Monitoring is an active plan, not simply waiting. It uses a baseline image and a stated reason to reassess, such as growth, thickening, new vessels, bleeding, or spread. Because specialists differ on biopsy, ask which finding would change the plan and whether the next comparison will use photographs. This approach recognizes that PAM can change naturally while repeated surgery or cryotherapy can scar the conjunctiva and cornea.
Prepare questions for your appointment
An appointment is easier to use when you bring a short timeline and clear questions. Write down when you first noticed the pigmentation, whether it has changed, and whether you have photographs from earlier dates.
Use questions such as these:
- Does the area look flat or raised, and is it on the conjunctiva or a deeper layer?
- Does the pattern fit PAM, a nevus, complexion-associated pigmentation, ocular melanocytosis, or another cause?
- Is the area in one eye or both, and does its location or extent change the level of concern?
- Do you recommend baseline photographs, repeat photographs, imaging, a biopsy, or another examination?
- If you recommend monitoring, what change should prompt an earlier visit?
- If you recommend a biopsy, what tissue question will it answer, and how could the result change treatment?
- What follow-up interval fits the findings in my eye?
For a large lesion occupying more than 5 to 6 clock hours, a 2013 guideline recommended removing suspicious areas and mapping all quadrants with an incisional biopsy, including areas that looked uninvolved. That size-based guidance is a question to discuss when the examination shows extensive pigmentation, not an instruction to measure the area yourself.
Do not use a mirror view to decide that a new or changing area is harmless. Record what you notice and arrange an examination.
Arrange an eye examination for these changes
A new pigmented spot on the eye needs a baseline examination. Arrange prompt ophthalmology assessment for a spot that shows rapid growth or thickening, mixed colors, new blood vessels, spread onto the cornea, or a new lump. These changes do not always mean cancer, but they need professional assessment because some lesions can transform into melanoma.
Those symptoms require faster attention than routine photographic monitoring.
When you contact an eye office, describe whether the pigmentation is new, changing, raised, painful, bleeding, or affecting vision. Bring earlier photographs if you have them. Do not wait for a routine follow-up interval if a previously documented area develops one of the warning changes above.
Take the next step toward a clear diagnosis
A new, changing, or previously unevaluated area of eye pigmentation deserves a clear baseline record. Bring your observations and earlier photographs so your eye doctor can compare the appearance, discuss whether monitoring or tissue assessment is appropriate, and explain the follow-up plan. An eye doctor must decide what the findings mean for your individual care.
Arrange an eye examination with us at Northwest Eye in Minnetonka if you need to discuss a pigmented area on the eye.
Questions about conjunctival melanosis evaluation and follow-up
How long can conjunctival melanosis last?
There is no single timeline for conjunctival melanosis. Primary acquired melanosis may remain dormant for years, progress slowly, or wax and wane in color and size. Follow-up depends on the lesion’s appearance, location, extent, and any changes. Ask your eye doctor what interval fits your findings and what changes should prompt an earlier visit.
Does a conjunctival melanosis biopsy always need to be done?
No, experts do not use one universal biopsy rule. Some recommend biopsy for every suspected primary acquired melanosis lesion, while others monitor flat lesions and biopsy when thickness, blood vessels, progression, or several risk factors appear. A biopsy can show whether atypia is present, which may change monitoring or treatment.
What should I bring to an appointment for conjunctival pigmentation?
Bring earlier eye photographs, a list of medicines, and notes about when you first noticed the area and whether it changed. Tell the eye doctor if it affects one or both eyes, is painful or bleeding, or has spread. These details help compare the lesion over time and plan examination, imaging, monitoring, or biopsy.
